logo

For the Inventor, By the Inventor

East Greenbush, NY, United States of America

Joseph C Collins

USPTO Granted Patents = 19

Average Co-Inventor Count = 1.6

ph-index = 3

Forward Citations = 39(Granted Patents)


Company Filing History:

goldMedal17 out of 692 
 
Sterling Drug Inc.
 patents
silverMedal2 out of 206 
 
Sterling Winthrop Inc.
 patents

Years Active: 1976-1995

Loading Chart...
19 patents (USPTO):Explore Patents
1. 5380749 - Thioxanthenone antitumor agents (1995-01-10),
2. 5346917 - Thioxanthenone antitumor agents (1994-09-13),
3. 4302462 - 4(or 3)-(3,4-Dihydroxyphenyl)pyridines, their cardiotonic use and (1981-11-24),
4. 4275201 - Aryl substituted diketones (1981-06-23),
5. 4246284 - Aminosulfonyl-substituted aryloxyalkyl diketones (1981-01-20),
6. 4227015 - Substituted phenylvinyl cyclopropyl ketones (1980-10-07),
7. 4198436 - Dialkylamino- and dialkylaminoalkoxy-substituted aryloxyalkyl diketones (1980-04-15),
8. 4189500 - Aryl substituted diketones (1980-02-19),
9. 4182761 - Acyloxy-substituted aryloxyalkyl diketones (1980-01-08),
10. 4182729 - Arylvinyl cyclopropyl ketones (1980-01-08),
11. 4182727 - 4-[6-(4-Cyanophenoxy)hexyl]-3,5-heptanedione (1980-01-08),
12. 4171378 - Aryl substituted diketones (1979-10-16),
13. 4171376 - Aryloxyalkyl keto-esters (1979-10-16),
14. 4166074 - Dialkylaminophenylethyl (or vinyl) cyclopropyl carbinols (1979-08-28),
15. 4133959 - Aryloxyalkyl diketones (1979-01-09),

Title: **Joseph C. Collins: Innovator in Antitumor Agents**

Introduction

Joseph C. Collins, a prolific inventor based in East Greenbush, NY, holds a remarkable portfolio of 19 patents. His contributions to the field of pharmaceuticals, particularly in the development of antitumor agents, have made a significant impact on cancer treatment methodologies.

Latest Patents

Among his latest innovations are the thioxanthenone antitumor agents, specifically the compounds 1-[[(Dialkylamino)alkyl]amino]-4-substituted-thioxanthen-9-ones. These compounds are disclosed as promising antitumor agents, with compositions that contain thioxanthenones. Collins' work also elucidates methods for treating tumors and cancer in mammals using these innovative agents.

Career Highlights

Joseph C. Collins has had a distinguished career, having worked with notable companies such as Sterling Drug Inc. and Sterling Winthrop Inc. His role in these organizations has enabled him to collaborate on research and development projects focused on advancing pharmaceutical innovations.

Collaborations

Throughout his career, Collins has collaborated with esteemed colleagues, including Guy D. Diana and Theodore C. Miller. These partnerships have enriched his work and contributed to the successful development of his patented inventions.

Conclusion

Joseph C. Collins exemplifies the spirit of innovation in the pharmaceutical industry. His dedication to creating effective antitumor agents through extensive research and collaboration continues to influence cancer treatment methodologies, marking him as a pivotal figure in the realm of medical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…